Pathstone Holdings’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,978
Closed -$335K 2363
2025
Q3
$335K Buy
+17,978
New +$336K ﹤0.01% 1980
2025
Q2
Sell
-29,380
Closed -$513K 2324
2025
Q1
$513K Sell
29,380
-14,215
-33% -$240K ﹤0.01% 1702
2024
Q4
$755K Sell
43,595
-40,326
-48% -$736K ﹤0.01% 1509
2024
Q3
$1.56M Sell
83,921
-42,549
-34% -$717K 0.01% 1130
2024
Q2
$1.95M Sell
126,470
-2,308
-2% -$33K 0.01% 928
2024
Q1
$1.9M Sell
128,778
-2,743
-2% -$38K 0.01% 935
2023
Q4
$1.88M Buy
+131,521
New +$1.87M 0.01% 775

Other funds holding SBRA

Pathstone Holdings's SBRA Position: Q4 2025 in Review

Pathstone Holdings sold out of Sabra Healthcare REIT (SBRA) in Q4 2025, closing a stake of 17,978 shares — an estimated $335K sold.

Pathstone Holdings first reported a position in SBRA in Q4 2023 and held it in 7 quarters. The position peaked at $1.95M in Q2 2024. 440 funds tracked by Wall St. Rank hold SBRA as of Q4 2025.

  • Pathstone Holdings reported no remaining Sabra Healthcare REIT position as of Q4 2025 after selling out during the quarter.
  • Pathstone Holdings sold 17,978 Sabra Healthcare REIT shares in Q4 2025, an estimated $335K.
  • Pathstone Holdings first reported a position in Sabra Healthcare REIT in Q4 2023 and held it in 7 quarters.
  • Pathstone Holdings's Sabra Healthcare REIT position peaked at $1.95M in Q2 2024.
  • 440 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2025.

Based on Pathstone Holdings's 13F filing for Q4 2025, filed 13 Feb 2026.